Article Text

other Versions

PDF
Catheter ablation for atrial fibrillation: who, why and does it work?
  1. S N Eyre-Brook,
  2. K Rajappan
  1. Department of Cardiology, Oxford University Hospitals NHS Trust, Oxford, UK
  1. Correspondence to K Rajappan, Oxford Heart Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK; kim.rajappan{at}ouh.nhs.uk

Abstract

Atrial fibrillation (AF) is the most common arrhythmia. For many years, treatment was predominantly pharmacological. The identification of signals from the pulmonary veins as critical to AF in many patients led to catheter ablation targeting these signals. Catheter ablation is more effective than antiarrhythmic drugs at restoring sinus rhythm, and may improve mortality, morbidity and quality of life in patients with symptomatic AF. There is evidence to suggest that catheter ablation would be even more beneficial if undertaken earlier in the disease process. Cost effectiveness of catheter ablation remains under assessment, but it does meet the NICE definition of cost efficacy and the figure improves as stroke risk rises. It is true that long-term data are lacking. However, until results of current long-term studies become available, ablation will continue to be reserved predominantly for patients with drug-refractory, symptomatic AF.

  • Atrial fibrillation
  • catheter
  • ablation
  • radiofrequency catheter
  • percutaneous catheter
  • pulmonary veins

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.